FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Hypoglossal Nerve, Implanted, Apnea

PMA: P250013 · Supplement: S001 · Decision Apr 30, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Stimulator, Hypoglossal Nerve, Implanted, Apnea
Trade Name
aura6000™ system
PMA Number
P250013
Supplement Number
S001
Device Class
FDA Class 3
Product Code
MNQ
Generic Name
Stimulator, hypoglossal nerve, implanted, apnea
Medical Specialty
Unknown
Advisory Committee
Anesthesiology
Decision
Approved
Decision Code
APPR
Decision Date
April 30, 2026
Date Received
March 31, 2026
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol
Expedited Review
N

Advisory Committee Statement

Approval of the protocol for the New Enrollment post-approval study (PAS) submitted to comply with the conditions of approval outlined in our approval order for P250013

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MNQ Stimulator, Hypoglossal Nerve, Implanted, Apnea